Results: 359

Endoclips as novel fiducial markers in trimodality bladder-preserving therapy of muscle-invasive bladder carcinoma: feasibility and patient outcomes

Int. braz. j. urol; 47 (1), 2021
ABSTRACT Hypothesis: Endoclip can be used as fiducial marker in urology. Objective: To assess the feasibility, cost effectiveness and reliability of endoclips as novel fiducial markers in precision radiotherapy, as part of a trimodality bladder-preserving treatment (TBPT) of muscle-invasive bladder car...

Immunohistochemical and clinicopathologic features of estrogen receptor-negative, progesterone receptor-positive, HER-2 negative breast carcinomas

SUMMARY OBJECTIVE: Currently, there is an ongoing debate whether progesterone receptor positive and estrogen receptor negative breast carcinomas represent a true distinct subtype of tumor or a mere immunohistochemical artifact. In this study, we conducted an immunohistochemistry panel with the antibodie...

Basal cell carcinoma with compromised margins: retrospective study of management, evolution, and prognosis

An. bras. dermatol; 96 (1), 2021
Abstract Background: Non-melanoma skin cancer is the most common type of malignancy in the Western world, and surgical excision is the preferred approach. The approach adopted in the face of incomplete excisions of basal cell carcinoma is still controversial. Objectives: To compare the number of tumor ...

Recurrencia de carcinoma papilar de tiroides en pacientes tiroidectomizados del Servicio Autónomo Oncológico del estado Lara
Recurrence of papillary carcinoma of thyroid in thyroidectomized patients from the Autonomous Oncological Service of Lara state

Bol. méd. postgrado; 37 (1), 2021
Con el objetivo de describir las recidivas de carcinoma papilar de tiroides (CPT) en pacientes tiroidectomizados atendidos en el Servicio Autónomo Oncológico del estado Lara, se realizó un estudio descriptivo transversal de recolección retrospectiva de datos de 140 historias clínicas de pacientes co...

Residual disease after operative hysteroscopy in patients with endometrioid endometrial cancer associated with polyps

Abstract Objective To evaluate the presence of residual disease in the uterine specimen after hysteroscopic polypectomy or polyp biopsy in patients with endometrioid endometrial cancer (EC). Methods We analyzed a series of 104 patients (92 cases from the Hospital AC Camargo and 12 from the Hospital d...

Efficacy of endometrial cancer follow-up protocols: time to change?

Abstract Objective The aim of the present study was to analyze relapse rates and patterns in patients with endometrial cancer with the aim of evaluating the effectiveness of current follow-up procedures in terms of patient survival, as well as the convenience of modifying the surveillance strategy. Me...

Routine follow-up after surgical treatment of lung cancer: is chest CT useful?

J. bras. pneumol; 47 (4), 2021
ABSTRACT Objective: To report the experience of a routine follow-up program based on medical visits and chest CT. Methods: This was a retrospective study involving patients followed after complete surgical resection of non-small cell lung cancer between April of 2007 and December of 2015. The follow-up...

Resultados del tratamiento del cáncer de tiroides

Rev. guatemalteca cir; 27 (1), 2021
El cáncer de tiroides es la neoplasia maligna más frecuente del sistema endocrino, siendo el más frecuente el cáncer bien diferenciado (papilar y folicular). El propósito de este trabajo es recoger nuestra experiencia clínica en el manejo y resultados del cáncer diferenciado de tiroides. Material ...

Long non-coding ribonucleic acid H19 and ten-eleven translocation enzyme 1 messenger RNA expression levels in uterine fibroids may predict their postoperative recurrence

Clinics; 76 (), 2021
OBJECTIVES: To investigate the predictive value of long non-coding RNA (lncRNA) H19 and the ten-eleven translocation enzyme 1 (TET1) transcriptional expression in postoperative recurrence of uterine fibroids (UFs). METHODS: Seventy-five patients with UF, who underwent surgical treatment, were enrolled i...